FDA Implements Agency-Wide AI Tool to Enhance Regulatory Processes

TL;DR Summary
The FDA has launched its agency-wide AI tool, Elsa, ahead of schedule, aiming to streamline clinical protocol reviews and speed up regulatory processes, as highlighted by Commissioner Marty Makary.
- FDA plans to begin rolling out AI tool agency-wide on Tuesday statnews.com
- FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People fda.gov
- How GenAI is already transforming regulatory writing for the life sciences Regulatory Affairs Professionals Society | RAPS
- FDA launches agency-wide AI tool Axios
- Template for GenAI geneonline.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 1 min read
Condensed
83%
173 → 29 words
Want the full story? Read the original article
Read on statnews.com